Diametric Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$581K Buy
+19,587
New +$561K 0.05% 333

Other funds holding LKFT

Diametric Capital's LKFT Position: Q3 2026 in Review

Diametric Capital opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 19,587 shares worth $581K. The stake represents 0.05% of the portfolio and ranks #333 among its holdings.

95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • Diametric Capital held 19,587 shares of Lakefront Biotherapeutics American Depositary Shares worth $581K as of Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Diametric Capital position in Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.05% of Diametric Capital's portfolio in Q3 2026, its #333 holding.
  • 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Diametric Capital's 13F filing for Q3 2026, filed 16 Nov 2026.